Cited by 204Diabetes Management and ResearchHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Treatment and Management

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Diabetic Ketoacidosis: Risk Factors and Management Strategies

Umpierrez, Guillermo E, Kitabchi, Abbas E·2003·Treatments in Endocrinology

Abstract

Diabetic ketoacidosis (DKA) is the most common hyperglycemic emergency in patients with diabetes mellitus. DKA most often occurs in patients with type 1 diabetes, but patients with type 2 diabetes are susceptible to DKA under stressful conditions, such as trauma, surgery, or infections. DKA is reported to be responsible for more than 100 000 hospital admissions per year in the US, and accounts for 4-9% of all hospital discharge summaries among patients with diabetes. Treatment of patients with DKA uses significant healthcare resources and accounts for 1 out of every 4 healthcare dollars spent on direct medical care for adult patients with type 1 diabetes in the US. Recent studies using standardized written guidelines for therapy have demonstrated a mortality rate of less than 5%, with higher mortality rates observed in elderly patients and those with concomitant life-threatening illnesses. Worldwide, infection is the most common precipitating cause for DKA, occurring in 30-50% of cases. Urinary tract infection and pneumonia account for the majority of infections. Other precipitating causes are intercurrent illnesses (i.e., surgery, trauma, myocardial ischemia, pancreatitis), psychological stress, and non-compliance with insulin therapy. The triad of uncontrolled hyperglycemia, metabolic acidosis and increased total body ketone concentration characterizes DKA. These metabolic derangements result from the combination of absolute or relative insulin deficiency and increased leve…

Overview

Integrity signals

Registry

Crossref · 10.2165/00024677-200302020-00003

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 115

  1. Kaufman, 1999, Pediatr Ann, 28, 576, 10.3928/0090-4481-19990901-09 · DOI
  2. Graves, 1997, Vital Health Stat, 130, 133
  3. Johnson, 1980, Mayo Clin Proc, 55, 83
  4. Faich, 1983, Am J Epidemiol, 117, 551, 10.1093/oxfordjournals.aje.a113577 · DOI
  5. Umpierrez, 1995, Diabetes, 44, 790, 10.2337/diab.44.7.790 · DOI
  6. Umpierrez, 1999, Diabetes Care, 22, 1517, 10.2337/diacare.22.9.1517 · DOI
  7. Balasubramanyam, 1999, Arch Intern Med, 159, 2317, 10.1001/archinte.159.19.2317 · DOI
  8. McFarlane, 2001, Diabet Med, 18, 10, 10.1046/j.1464-5491.2001.00395.x · DOI
  9. Geiss, 1993, MMWR CDC Surveill Summ, 42, 1
  10. 1994, Diabetologia, 37, 278, 10.1007/BF00398055 · DOI
  11. Ellemann, 1984, Diabetes Care, 7, 528, 10.2337/diacare.7.6.528 · DOI
  12. Wright, 1990, Diabet Med, 7, 628, 10.1111/j.1464-5491.1990.tb01462.x · DOI
  13. Umpierrez, 1997, Arch Intern Med, 157, 669, 10.1001/archinte.1997.00440270117011 · DOI
  14. Javor, 1997, Diabetes Care, 20, 349, 10.2337/diacare.20.3.349 · DOI
  15. Kitabchi, 2001, Diabetes Care, 24, 131, 10.2337/diacare.24.1.131 · DOI
  16. Moss, 1987, South Med J, 80, 875, 10.1097/00007611-198707000-00017 · DOI
  17. Wagner, 1999, Diabetes Care, 22, 674, 10.2337/diacare.22.5.674 · DOI
  18. White, 2000, Endocrinol Metab Clin North Am, 29, 657, 10.1016/S0889-8529(05)70158-4 · DOI
  19. Basu, 1993, Diabet Med, 10, 282, 10.1111/j.1464-5491.1993.tb00060.x · DOI
  20. Malone, 1992, J Am Geriatr Soc, 40, 1100, 10.1111/j.1532-5415.1992.tb01797.x · DOI
  21. Scibilia, 1986, Acta Endocrinol Suppl (Copenh), 279, 326, 10.1530/acta.0.112S326 · DOI
  22. Umpierrez, 1996, Am J Med Sci, 311, 225, 10.1016/S0002-9629(15)41700-8 · DOI
  23. Rwiza, 1986, Diabet Med, 3, 181, 10.1111/j.1464-5491.1986.tb00738.x · DOI
  24. Polonsky, 1994, Diabetes Care, 17, 1178, 10.2337/diacare.17.10.1178 · DOI
  25. Rydall, 1997, N Engl J Med, 336, 1849, 10.1056/NEJM199706263362601 · DOI
  26. Musey, 1995, Diabetes Care, 18, 483, 10.2337/diacare.18.4.483 · DOI
  27. Teutsch, 1984, N Engl J Med, 310, 361, 10.1056/NEJM198402093100606 · DOI
  28. Bending, 1985, Am J Med, 79, 685, 10.1016/0002-9343(85)90518-2 · DOI
  29. Siperstein, 1992, Endocrinol Metab Clin North Am, 21, 415, 10.1016/S0889-8529(18)30224-X · DOI
  30. Delaney, 2000, Endocrinol Metab Clin North Am, 29, 683, 10.1016/S0889-8529(05)70159-6 · DOI
  31. Kitabchi, 1995, Med Clin North Am, 79, 9, 10.1016/S0025-7125(16)30082-7 · DOI
  32. Merimee, 1974, N Engl J Med, 291, 1275, 10.1056/NEJM197412122912404 · DOI
  33. DeFronzo, 1994, Diabetes Rev, 2, 209
  34. Felig, 1979, Recent Prog Horm Res, 35, 501
  35. Gerich, 1976, J Clin Invest, 57, 875, 10.1172/JCI108364 · DOI · Paper page
  36. McGarry, 1989, Diabetes Metab Rev, 5, 271, 10.1002/dmr.5610050305 · DOI
  37. Foster, 1983, N Engl J Med, 309, 159, 10.1056/NEJM198307213090307 · DOI · Paper page
  38. van de Werve, 1987, Diabetes Metab Rev, 3, 47, 10.1002/dmr.5610030104 · DOI
  39. Exton, 1987, Diabetes Metab Rev, 3, 163, 10.1002/dmr.5610030108 · DOI
  40. Robertson, 1994, Diabetes, 43, 1085, 10.2337/diab.43.9.1085 · DOI · Paper page
  41. Rossetti, 1990, Diabetes Care, 13, 610, 10.2337/diacare.13.6.610 · DOI
  42. Yki-Jarvinen, 1992, Endocr Rev, 13, 415
  43. Giddings, 1982, Diabetes, 31, 624, 10.2337/diab.31.7.624 · DOI
  44. McGarry, 1979, Diabetes, 28, 517, 10.2337/diab.28.5.517 · DOI
  45. Cook, 1978, J Biol Chem, 253, 2529, 10.1016/S0021-9258(17)40853-2 · DOI
  46. Reichard, 1986, Diabetes, 35, 668, 10.2337/diab.35.6.668 · DOI
  47. Campbell, 1975, JAMA, 233, 166, 10.1001/jama.1975.03260020052026 · DOI
  48. Fraser, 1990, Diabetologia, 33, 675, 10.1007/BF00400569 · DOI
  49. de Boer, 1994, Diabetologia, 37, 75, 10.1007/BF00428781 · DOI
  50. Umpierrez, 2002, J Crit Care, 17, 63, 10.1053/jcrc.2002.33030 · DOI
  51. Jenkins, 1993, Acta Diabetol, 30, 251, 10.1007/BF00569937 · DOI
  52. Munro, 1973, BMJ, 2, 578, 10.1136/bmj.2.5866.578 · DOI
  53. Byrne, 2000, Diabetes Care, 23, 500, 10.2337/diacare.23.4.500 · DOI
  54. Alberti, 1972, BMJ, 2, 565, 10.1136/bmj.2.5813.565 · DOI
  55. Umpierrez, 2000, J Crit Care, 15, 52, 10.1053/jcrc.2000.7900 · DOI
  56. Umpierrez, 1995, Diabetes Care, 18, 137, 10.2337/diacare.18.1.137 · DOI · Paper page
  57. Winter, 1990, Arch Intern Med, 150, 311, 10.1001/archinte.1990.00390140057012 · DOI
  58. Adrogue, 1982, N Engl J Med, 307, 1603, 10.1056/NEJM198212233072603 · DOI
  59. Adrogue, 1984, Kidney Int, 25, 591, 10.1038/ki.1984.62 · DOI
  60. Kaminska, 1993, Am J Emerg Med, 11, 77, 10.1016/0735-6757(93)90066-K · DOI
  61. Adrogue, 1986, Medicine (Baltimore), 65, 163, 10.1097/00005792-198605000-00004 · DOI
  62. Lebovitz, 1995, Lancet, 345, 767, 10.1016/S0140-6736(95)90645-2 · DOI
  63. Slovis, 1987, Am J Emerg Med, 5, 1, 10.1016/0735-6757(87)90280-4 · DOI
  64. Vinicor, 1979, Ann Intern Med, 91, 200, 10.7326/0003-4819-91-2-200 · DOI
  65. Vantyghem, 1999, Acta Diabetol, 36, 39, 10.1007/s005920050143 · DOI
  66. Yadav, 2000, Am J Gastroenterol, 95, 3123, 10.1111/j.1572-0241.2000.03279.x · DOI
  67. Nair, 2000, Am J Gastroenterol, 95, 2795, 10.1111/j.1572-0241.2000.03188.x · DOI
  68. Wrenn, 1991, Am J Med, 91, 119, 10.1016/0002-9343(91)90003-G · DOI
  69. Bleich, 1977, N Engl J Med, 296, 612, 10.1056/NEJM197703172961106 · DOI
  70. Cahill, 1981, Kidney Int, 20, 416, 10.1038/ki.1981.155 · DOI
  71. Barrett, 1984, Hosp Pract (Off Ed), 19, 89, 10.1080/21548331.1984.11702796 · DOI
  72. Cahill, 1970, N Engl J Med, 282, 668, 10.1056/NEJM197003052821026 · DOI
  73. May, 1993, Am J Med Sci, 306, 287, 10.1097/00000441-199311000-00003 · DOI
  74. Waldhausl, 1979, Diabetes, 28, 577, 10.2337/diab.28.6.577 · DOI
  75. Owen, 1981, Diabetes, 30, 510, 10.2337/diab.30.6.510 · DOI
  76. Pinies, 1994, Diabete Metab, 20, 43
  77. Hillman, 1987, Intensive Care Med, 13, 4, 10.1007/BF00263548 · DOI
  78. Alberti, 1973, Lancet, II, 515, 10.1016/S0140-6736(73)92346-5 · DOI
  79. Burghen, 1980, Diabetes Care, 3, 15, 10.2337/diacare.3.1.15 · DOI
  80. Fisher, 1977, N Engl J Med, 297, 238, 10.1056/NEJM197708042970502 · DOI
  81. Page, 1974, BMJ, 2, 687, 10.1136/bmj.2.5921.687 · DOI
  82. Luzi, 1988, Diabetes, 37, 1470, 10.2337/diab.37.11.1470 · DOI
  83. Sacks, 1979, Ann Intern Med, 90, 36, 10.7326/0003-4819-90-1-36 · DOI
  84. Abramson, 1966, JAMA, 196, 401, 10.1001/jama.1966.03100180069021 · DOI
  85. McCurdy, 1970, Med Clin North Am, 54, 683, 10.1016/S0025-7125(16)32636-0 · DOI
  86. DeFronzo, 1980, Am J Physiol, 238, E421
  87. Mitchell, 1972, Kidney Int, 1, 375, 10.1038/ki.1972.48 · DOI
  88. Housley, 1970, Cardiovasc Res, 4, 482, 10.1093/cvr/4.4.482 · DOI
  89. Soler, 1972, Lancet, II, 665, 10.1016/S0140-6736(72)92083-1 · DOI
  90. Morris, 1986, Ann Intern Med, 105, 836, 10.7326/0003-4819-105-6-836 · DOI
  91. Lever, 1983, Am J Med, 75, 263, 10.1016/0002-9343(83)91203-2 · DOI
  92. Fisher, 1983, J Clin Endocrinol Metab, 57, 177, 10.1210/jcem-57-1-177 · DOI
  93. Wilson, 1982, Arch Intern Med, 142, 517, 10.1001/archinte.1982.00340160097021 · DOI
  94. Winter, 1979, Am J Med, 67, 897, 10.1016/0002-9343(79)90751-4 · DOI
  95. Alberti, 1972, Lancet, II, 391, 10.1016/S0140-6736(72)91793-X · DOI
  96. Gibby, 1978, Diabetologia, 15, 381, 10.1007/BF01219647 · DOI
  97. Kreisberg, 1977, Hosp Pract, 12, 121, 10.1080/21548331.1977.11707099 · DOI
  98. Kreisberg, 1987, Crit Care Clin, 3, 817, 10.1016/S0749-0704(18)30521-9 · DOI
  99. Rattarasarn, 1994, Diabetes, 43, 809, 10.2337/diab.43.6.809 · DOI
  100. Bello, 1990, Lancet, 336, 64, 10.1016/0140-6736(90)91587-Z · DOI
  101. Duck, 1988, J Pediatr, 113, 10, 10.1016/S0022-3476(88)80521-3 · DOI
  102. Rosenbloom, 1990, Diabetes Care, 13, 22, 10.2337/diacare.13.1.22 · DOI
  103. Glaser, 2001, N Engl J Med, 344, 264, 10.1056/NEJM200101253440404 · DOI
  104. Silver, 1997, Kidney Int, 51, 1237, 10.1038/ki.1997.169 · DOI
  105. Lorber, 1993, Endocrinologist, 3, 29, 10.1097/00019616-199301000-00006 · DOI
  106. Beech, 1989, Biochem J, 263, 737, 10.1042/bj2630737 · DOI
  107. Paton, 1981, Diabetologia, 21, 172, 10.1007/BF00252650 · DOI
  108. Hamblin, 1989, Med J Aust, 151, 439, 10.5694/j.1326-5377.1989.tb101253.x · DOI
  109. Buyukasik, 1998, Diabetes Care, 21, 868, 10.2337/diacare.21.5.868 · DOI
  110. Faigel, 1996, Dig Dis Sci, 41, 1, 10.1007/BF02208576 · DOI
  111. Wang, 1994, Diabetes Res Clin Pract, 26, 209, 10.1016/0168-8227(94)90062-0 · DOI
  112. Umpierrez, 2002, Diabetes Spectrum, 15, 28, 10.2337/diaspect.15.1.28 · DOI
  113. Laffel, 1998, Qual Manag Health Care, 6, 53, 10.1097/00019514-199806040-00006 · DOI
  114. Laffel, 2000, Endocrinol Metab Clin North Am, 29, 707, 10.1016/S0889-8529(05)70160-2 · DOI
  115. MacGillivray, 1982, J Clin Endocrinol Metab, 54, 665, 10.1210/jcem-54-3-665 · DOI

Cited by

Sorted by citations

See all 204

Metadata

Authors
Umpierrez, G. E., & Kitabchi, A. E.
Affiliations
University of Tennessee Health Science Center (US)
Corresponding author
Umpierrez, Guillermo E
Venue
Treatments in Endocrinology
Published
2003
Volume
2
Issue
2
Pages
95-108
ISSN
1175-6349 (ISSN-L)
OpenAlex
W2055653312
Cited by
204
References
3
Citations by year
2026: 12 · 2025: 11 · 2024: 9 · 2023: 19 · 2022: 14 · 2021: 26 · 2020: 12 · 2019: 9 · 2018: 7 · 2017: 7 · 2016: 10 · 2015: 9 · 2014: 8 · 2013: 8 · 2012: 5
FWCI
2.01
Type
journal article
Language
en
Open access
closed
Locations
  • Treatments in Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
diabetic ketoacidosis, type 1 diabetes, type 2 diabetes, hyperglycemic emergencies, precipitating factors, infection, insulin deficiency, counterregulatory hormones, metabolic acidosis, ketone bodies, DKA prevention, diabetes education, hospitalization, mortality
MeSH terms
Acidosis, Bicarbonates, Diabetes Mellitus, Type 1, Diagnosis, Differential, Fluid Therapy, Humans, Insulin, Ketones, Phosphates, Potassium, Risk Factors, Diabetic Ketoacidosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review